The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Maarten J. Postma

Groningen University Institute for Drug Exploration/Groningen Research Institute of Pharmacy The Netherlands

Netherlands

[email]@farm.rug.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Groningen University Institute for Drug Exploration/Groningen Research Institute of Pharmacy The Netherlands, Netherlands. 2000 - 2004
  • Groningen University Institute for Drug Exploration/University of Groningen Research Institute of Pharmacy (GUIDE/GRIP), Department of Social Pharmacy, Pharmaco-epidemiology & Pharmacotherapy, Netherlands. 2003
  • Groningen University for Drug Exploration (GUIDE), Groningen, Netherlands. 2000
  • National Institute of Public Health and the Environment, Bilthoven, Netherlands. 1999

References

  1. Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations. Postma, M.J., Bos, J.M., Welte, R., de Groot, R., Luytjes, W., Rümke, H.C., Beutels, P. Eur. J. Health. Econ (2004) [Pubmed]
  2. Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery. Postma, M.J., van de Watering, L.M., de Vries, R., Versmoren, D., van Hulst, M., Tobi, H., van der Poel, C.L., Brand, A. Vox Sang. (2003) [Pubmed]
  3. Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetes. Postma, M.J., Kruidhof, H., de Jong-van den Berg, L.T., de Zeeuw, D. Expert. Opin. Pharmacother (2003) [Pubmed]
  4. Pharmacoeconomic research. Postma, M.J. Pharm. World. Sci (2003) [Pubmed]
  5. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands. Postma, M.J., Heijnen, M.L., Beutels, P., Jager, J.C. Expert. Rev. Vaccines (2003) [Pubmed]
  6. Cost-effectiveness of periconceptional supplementation of folic acid. Postma, M.J., Londeman, J., Veenstra, M., de Walle, H.E., de Jong-van den Berg, L.T. Pharm. World. Sci (2002) [Pubmed]
  7. Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. Postma, M.J., Heijnen, M.L., Jager, J.C. Pharmacoeconomics (2001) [Pubmed]
  8. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis. Postma, M.J., Welte, R., van den Hoek, J.A., van Doornum, G.J., Jager, H.C., Coutinho, R.A. Value. Health (2001) [Pubmed]
  9. Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence. Postma, M.J., Baltussen, R.M., Heijnen, M.L., de Berg, L.T., Jager, J.C. Drugs. Aging (2000) [Pubmed]
  10. Socio-economic aspects of extended STD screening in pregnancy. Postma, M.J., Jager, J.C., de Jong-van den Berg, L.T. AIDS. Care (2000) [Pubmed]
  11. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Postma, M.J., Bos, J.M., van Gennep, M., Jager, J.C., Baltussen, R., Sprenger, M.J. Pharmacoeconomics (1999) [Pubmed]
 
WikiGenes - Universities